Company profile

Neurophet., Inc.

Neurophet., Inc. has 5 AI-enabled medical devices on the FDA list. The first decision was on May 10, 2023 and the most recent on May 15, 2026 (Neurophet SCALE PET). Its most common review panel is Radiology (5 devices).

5AI devices

2023First decision

2026Latest decision

1Specialties

Per year

202320242026

Neurophet., Inc. AI devices per year: 2023 1, 2024 1, 2026 3

By specialty

Radiology5

Related guides

Top radiology devices

Timeline

May 15, 2026 · 510(k) K252563Neurophet SCALE PET · Radiology · QIH
May 15, 2026 · 510(k) K261273Neurophet AQUA · Radiology · QIH
January 29, 2026 · 510(k) K252496Neurophet AQUA AD Plus · Radiology · QIH
October 25, 2024 · 510(k) K242215Neurophet AQUA (V3.1) · Radiology · QIH
May 10, 2023 · 510(k) K220437Neurophet AQUA · Radiology · LLZ